Procedural and Intermediate-term Results of the Electroanatomical-guided Cardioneuroablation for the Treatment of Supra-Hisian Second- or Advanced-degree Atrioventricular Block: the PIRECNA multicentre registry.


Journal

Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology
ISSN: 1532-2092
Titre abrégé: Europace
Pays: England
ID NLM: 100883649

Informations de publication

Date de publication:
02 Jul 2024
Historique:
received: 28 02 2024
accepted: 18 04 2024
medline: 31 7 2024
pubmed: 31 7 2024
entrez: 31 7 2024
Statut: ppublish

Résumé

Prior case series showed promising results for cardioneuroablation in patients with vagally induced atrioventricular blocks (VAVBs). We aimed to examine the acute procedural characteristics and intermediate-term outcomes of electroanatomical-guided cardioneuroablation (EACNA) in patients with VAVB. This international multicentre retrospective registry included data collected from 20 centres. Patients presenting with symptomatic paroxysmal or persistent VAVB were included in the study. All patients underwent EACNA. Procedural success was defined by the acute reversal of atrioventricular blocks (AVBs) and complete abolition of atropine response. The primary outcome was occurrence of syncope and daytime second- or advanced-degree AVB on serial prolonged electrocardiogram monitoring during follow-up. A total of 130 patients underwent EACNA. Acute procedural success was achieved in 96.2% of the cases. During a median follow-up of 300 days (150, 496), the primary outcome occurred in 17/125 (14%) cases with acute procedural success (recurrence of AVB in 9 and new syncope in 8 cases). Operator experience and use of extracardiac vagal stimulation were similar for patients with and without primary outcomes. A history of atrial fibrillation, hypertension, and coronary artery disease was associated with a higher primary outcome occurrence. Only four patients with primary outcome required pacemaker placement during follow-up. This is the largest multicentre study demonstrating the feasibility of EACNA with encouraging intermediate-term outcomes in selected patients with VAVB. Studies investigating the effect on burden of daytime symptoms caused by the AVB are required to confirm these findings.

Identifiants

pubmed: 39082707
pii: 7708232
doi: 10.1093/europace/euae164
pii:
doi:

Types de publication

Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) 2024. Published by Oxford University Press on behalf of the European Society of Cardiology.

Déclaration de conflit d'intérêts

Conflict of interest: none declared.

Auteurs

Tolga Aksu (T)

Department of Cardiology, Yeditepe University Hospital, Icerenkoy Mah. Hastahane Sok. 4, 34752, Istanbul, Turkey.

Roman Piotrowski (R)

Centre of Postgraduate Medical Education, Department of Cardiology, Grochowski Hospital, 01-809, Warsaw, Poland.

Roderick Tung (R)

The University of Arizona College of Medicine-Phoenix, Department of Cardiology, Banner University Medical Center, Phoenix, AZ 85004, USA.

Tom De Potter (T)

Cardiovascular Center, OLV Hospital, Aalst, 9300, Belgium.

Timothy M Markman (TM)

Division of Cardiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.

Jeanne du Fay de Lavallaz (J)

Department of Cardiology, University Hospital Basel, Petersgraben 4, 4031 Basel, Switzerland.

Roin Rekvava (R)

Department of Rhythm Management and Electrophysiology, American Hospital Tbilisi, Tbilisi 01102, Georgia.

Daniel Alyesh (D)

South Denver Cardiology Associates, Littleton, CO 80120, USA.

Jacqueline E Joza (JE)

Department of Cardiology, McGill University, Montreal, QC, H3A 0G4, Canada.

Patrick Badertscher (P)

Department of Cardiology, University Hospital Basel, Petersgraben 4, 4031 Basel, Switzerland.

Duc H Do (DH)

UCLA Cardiac Arrhythmia Center, Ronald Reagan UCLA Medical Center, 100 Medical Plaza, Suite 660, Los Angeles, CA 90095, USA.

Jason S Bradfield (JS)

UCLA Cardiac Arrhythmia Center, Ronald Reagan UCLA Medical Center, 100 Medical Plaza, Suite 660, Los Angeles, CA 90095, USA.

Gaurav Upadhyay (G)

Section of Cardiology, Center for Arrhythmia Care, University of Chicago Medicine, Chicago, IL 60637, USA.

Nitesh Sood (N)

Department of Cardiology, Southcoast Health, Fall River, MA 02720, USA.

Parikshit S Sharma (PS)

Division of Cardiology, Rush University Medical Center, 1717 West Congress Parkway, Chicago, IL 60612, USA.

Tumer Erdem Guler (TE)

Division of Cardiology, Kocaeli State Hospital, Kocaeli, 41060, Turkey.

Enes Elvin Gul (EE)

Division of Cardiology, Atlas University, Medicine Hospital, Istanbul, 34203, Turkey.

Vineet Kumar (V)

Inova Medical Group, Arrhythmia 8081 Innovation Park Dr 602, Fairfax, VA 22031, USA.

Buelent Koektuerk (B)

Department of Cardiology, Witten/Herdecke University, Witten, D-58455, Germany.
Department of Cardiology and Electrophysiology, Sana Clinics Düsseldorf, Düsseldorf, 40625, Germany.

Alexander Romeno Janner Dal Forno (ARJ)

Department of Cardiology, Hospital SOS Cardio, Florianópolis, SC, 88030-000, Brazil.

Christopher E Woods (CE)

Department of Cardiology, California Pacific Medical Center, San Francisco, CA 94110, USA.

Moshe Rav-Acha (M)

Jesselson Integrated Heart Center, Shaare Zedek Medical Center and Hebrew University Faculty of Medicine, PO Box 3235, Jerusalem 9103102, Israel.

Chiara Valeriano (C)

Cardiovascular Center, OLV Hospital, Aalst, 9300, Belgium.

Andres Enriquez (A)

Division of Cardiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
Division of Cardiology, Queen's University, Kingston, ON K7l 3N6, Canada.

Sri Sundaram (S)

South Denver Cardiology Associates, Littleton, CO 80120, USA.

Michael Glikson (M)

Jesselson Integrated Heart Center, Shaare Zedek Medical Center and Hebrew University Faculty of Medicine, PO Box 3235, Jerusalem 9103102, Israel.

Andre d'Avila (A)

Beth Israel Deaconess Medical Center, Harvard Thorndike Electrophysiology Institute, Boston, MA 02215, USA.

Kalyanam Shivkumar (K)

UCLA Cardiac Arrhythmia Center, Ronald Reagan UCLA Medical Center, 100 Medical Plaza, Suite 660, Los Angeles, CA 90095, USA.

Piotr Kulakowski (P)

Centre of Postgraduate Medical Education, Department of Cardiology, Grochowski Hospital, 01-809, Warsaw, Poland.

Henry D Huang (HD)

Division of Cardiology, Rush University Medical Center, 1717 West Congress Parkway, Chicago, IL 60612, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH